Manuscripts

Search by keyword, year, or author name.

Showing 1591 manuscripts.

Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA.

A. Saitoh, Terence Fenton, Ed.D., Karen Hsia, Ph.D., Christine Powell, M.A., Cindy Christopherson, Courtney V. Fletcher, Pharm.D., Stuart E. Starr, M.D., Stephen A. Spector, M.D. Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA. Journal of Infectious Diseases. 2002 May 15; 185(10):1409-16.

Year

2002

Journal

Journal of Infectious Diseases

Lack of improvement in growth in HIV-infected children receiving ritonavir-containing highly active antiretroviral therapy

Sharon Appelbaum Nachman, M.D., Jane C. Lindsey, Sc.D., Ph.D., Stephen Ira Pelton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Ram Yogev, M.D. Lack of improvement in growth in HIV-infected children receiving ritonavir-containing highly active antiretroviral therapy. Archives of Pediatrics and Adolescent Medicine. 2002 May 01; 156(5):497-503.

Year

2002

Journal

Archives of Pediatrics and Adolescent Medicine

Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.

Mark Mirochnick, M.D., Suzanne Siminski, M.S., M.B.A., Terence Fenton, Ed.D., M. Lugo, John L. Sullivan, M.D. Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure. Journal of Infectious Diseases. 2002 Jul 15; 2(186):181-8.

Year

2002

Journal

Journal of Infectious Diseases

Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors

Ingrid A. Beck, M.S., Madhumita S. Mahalanabis, G. Pepper, A. Wright, Scott Hamilton, R.N., E. Langston, Lisa M. Frenkel, M.D. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors. Journal of Clinical Microbiology. 2002 Apr 01; 40(4):1413-9. PMID: 11923366; PMCID: PMC140364.

Year

2002

Journal

Journal of Clinical Microbiology

Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays

John L. Schmitz, Ph.D., Thomas Denny, B.S., M.Sc., Ambrosia Garcia-Louzao, M.S., Janet L. Lathey, Ph.D. Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays. Clinical and Diagnostic Laboratory Immunology. 2002 May 01; 9(3):525-9.

Year

2002

Journal

Clinical and Diagnostic Laboratory Immunology

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection

Courtney V. Fletcher, Pharm.D., Peter Anderson, Pharm.D., Thomas N Kakuda, Pharm.D., Timothy Schacker, M.D., W. Keith Henry, M.D., Cynthia R. Gross, Richard Brundage, Pharm.D., Ph.D. Concentration-controlled compared with conventional antiretroviral therapy for HIV infection. AIDS. 2002 Mar 08; 16(4):551-60.

Year

2002

Journal

AIDS

Stavudine, Nevirapine, and Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children (Pediatric AIDS Treatment Group Protocol 338 Step 2)

Ram Yogev, M.D., Sophia S. Lee, M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Kenneth Stanley, Ph.D., Stephen Ira Pelton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Susan A. Fiscus, Ph.D., Eleanor Jimenez, M.D., F.A.A.P., Mobeen H. Rathore, M.D., Elizabeth (Betsy) Smith, M.D., Kenneth McIntosh, M.D. Stavudine, Nevirapine, and Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children (Pediatric AIDS Treatment Group Protocol 338 Step 2). Pediatric Infectious Disease Journal. 2002 Feb 21; 2:119-25.

Year

2002

Journal

Pediatric Infectious Disease Journal

Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission

Alejandro Dorenbaum, M.D., Coleen Cunningham, M.D., Richard D. Gelber, Ph.D., Mary Culnane, C.R.N.P., M.S., Lynne M. Mofenson, M.D., F.A.A.P., Paula Britto, M.S., Claire Rekacewicz, M.D., Marie Louise Newell, M.D., Jean-Francois Delfraissy, M.D., Bethann Cunningham-Schrader, B.A., M.S., Mark Mirochnick, M.D., John L. Sullivan, M.D. Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission. The Journal of the American Medical Association. 2002 Jul 11; 288(2):189-198.

Year

2002

Journal

The Journal of the American Medical Association

Efavirenz liquid Formulation in human immunodeficiency virus-infected children.

Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D., Richard Brundage, Pharm.D., Ph.D., Florence H. Yong, M.S., Steven D. Douglas, M.D., Patricia M. Flynn, M.D., M.S., Mark W. Kline, M.D., Patricia M. Flynn, M.D., M.S. Efavirenz liquid Formulation in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal. 2002 Dec 23; 21(7):659-63.

Year

2002

Journal

Pediatric Infectious Disease Journal

Concentrations of protease inhibitors in cord blood after in utero exposure.

Mark Mirochnick, M.D., Alejandro Dorenbaum, M.D., Diane Holland, M.Phil., Bethann Cunningham-Schrader, B.A., M.S., Coleen K. Cunningham, M.D., Coleen Cunningham, M.D., Bethann Cunningham-Schrader, B.A., M.S., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., James D. Connor, M.D., John L. Sullivan, M.D. Concentrations of protease inhibitors in cord blood after in utero exposure. Pediatric Infectious Disease Journal. 2002 Dec 17; 21(9):835-8.

Year

2002

Journal

Pediatric Infectious Disease Journal